KIAA0090 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.586800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.131600E-01
Normal-vs-Stage2
5.587600E-01
Normal-vs-Stage3
5.493200E-01
Normal-vs-Stage4
7.287500E-02
Stage1-vs-Stage2
7.983800E-02
Stage1-vs-Stage3
3.787000E-01
Stage1-vs-Stage4
1.612370E-02
Stage2-vs-Stage3
2.272800E-01
Stage2-vs-Stage4
1.165410E-01
Stage3-vs-Stage4
3.839600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.514200E-01
Normal-vs-AfricanAmerican
4.188200E-01
Normal-vs-Asian
9.530000E-01
Caucasian-vs-AfricanAmerican
8.766600E-01
Caucasian-vs-Asian
2.969400E-01
AfricanAmerican-vs-Asian
3.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.851600E-01
Normal-vs-Female
5.215200E-01
Male-vs-Female
3.157800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.896600E-01
Normal-vs-Age(41-60Yrs)
3.213000E-01
Normal-vs-Age(61-80Yrs)
6.890000E-01
Normal-vs-Age(81-100Yrs)
8.832200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.670430E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.651400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.294600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.924100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.259210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.425000E-01
Normal-vs-Daily Drinker
6.932200E-01
Normal-vs-Weekly Drinker
5.794400E-01
Normal-vs-Occasional Drinker
1.689760E-01
Normal-vs-Social Drinker
4.990200E-01
Non Drinker-vs-Daily Drinker
7.293000E-01
Non Drinker-vs-Weekly Drinker
3.847400E-01
Non Drinker-vs-Occasional Drinker
4.711900E-02
Non Drinker-vs-Social Drinker
4.162200E-01
Daily Drinker-vs-Weekly Drinker
4.652000E-01
Daily Drinker-vs-Occasional Drinker
1.620020E-02
Daily Drinker-vs-Social Drinker
4.055400E-01
Weekly Drinker-vs-Occasional Drinker
3.714200E-01
Weekly Drinker-vs-Social Drinker
8.811200E-01
Occasional Drinker-vs-Social Drinker
2.028200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.493000E-01
Normal-vs-Grade 2
7.823200E-01
Normal-vs-Grade 3
8.311200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.977600E-01
Grade 1-vs-Grade 3
1.159970E-01
Grade 1-vs-Grade 4
7.493000E-01
Grade 2-vs-Grade 3
2.158000E-01
Grade 2-vs-Grade 4
7.823200E-01
Grade 3-vs-Grade 4
8.311200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.987000E-01
Normal-vs-NonDiabetic
5.966400E-01
Diabetic-vs-NonDiabetic
4.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.578800E-01
Normal-vs-NoPancreatitis
5.735400E-01
Pancreatitis-vs-NoPancreatitis
4.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.532400E-01
Normal-vs-N1
5.393600E-01
N0-vs-N1
3.879800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.097000E-03
Normal-vs-TP53-NonMutant
7.970000E-01
TP53-Mutant-vs-TP53-NonMutant
4.197100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
